Rapport Therapeutics, Inc. RAPP Total debt

Total debt at other companies

Bristol-Myers SquibbBMY

$43.33B-12.3%

Supernus PharmaceuticalsSUPN

$40.9M+26.6%

Xenon PharmaceuticalsXENE

$6.42M-26.4%

Praxis Precision Medicines, Inc.PRAX

$1.09M+44.0%

BiohavenBHVN

$286.18M+706%

Septerna, Inc.SEPN

$23.09M-7.7%

FAQ

What is Rapport Therapeutics, Inc.'s total debt?

Rapport Therapeutics, Inc. (RAPP) reported total debt of $10.11M in Q2 2026.

How has Rapport Therapeutics, Inc.'s total debt changed year-over-year?

Rapport Therapeutics, Inc.'s total debt decreased by 14.8% year-over-year, from $11.86M to $10.11M.

What is the long-term trend for Rapport Therapeutics, Inc.'s total debt?

Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s total debt has grown at a 131.3% compound annual growth rate (CAGR), from $2.15M to $11.48M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.